Complications of Pancreatic Surgery — MCQs
What are the indications for surgical intervention in a patient with pancreatic ascites?
In acute pancreatitis, organ failure beyond 48 hours indicates:
Most common immediate complication after splenectomy?
Exocrine pancreatic insufficiency is seen in:
Patients with chronic pancreatitis often exhibit a "chain of lakes" appearance in ERCP examinations. Management is?
Which of the following is not considered a contraindication for pancreaticoduodenectomy?
Which of the following is not a recognized complication of chronic pancreatitis?
Pancreatic pseudocysts developing complications are best managed by?
After pancreaticoduodenectomy (PD surgery), when should the first postoperative follow-up visit be scheduled to assess the patient's recovery?
What is the median survival time for patients with carcinoma of the pancreas after surgery and adjuvant therapy?
Complications of Pancreatic Surgery Indian Medical PG Practice Questions and MCQs
Question 1: What are the indications for surgical intervention in a patient with pancreatic ascites?
- A. Initial leak from stented duct
- B. Persistent leak from a stented duct (Correct Answer)
- C. Persistent symptoms despite medical management
- D. Recurrent ascites after drainage with ongoing symptoms
Explanation: **Persistent leak from a stented duct** - This indicates that **endoscopic drainage** or stenting has failed to resolve the pancreatic duct leak, requiring a more definitive surgical approach. - **Ongoing leakage** despite internal drainage attempts suggests a persistent anatomical disruption that only surgery can effectively repair. *Persistent symptoms despite medical management* - While persistent symptoms warrant further intervention, this option is too broad and does not specifically point to the failure of less invasive procedures like endoscopic stenting. - Symptoms alone, without evidence of a failed specific intervention, might lead to other non-surgical interventions first. *Initial leak from stented duct* - An initial leak is often managed with **endoscopic stent placement** as the primary, less invasive intervention. - Surgical intervention is typically reserved for cases where initial stenting and conservative measures fail. *Recurrent ascites after drainage with ongoing symptoms* - **Recurrent ascites** after simple drainage (paracentesis) only suggests a persistent leak, but this option does not mention the failure of a stented duct. - The next step after drainage would likely be **endoscopic retrograde cholangiopancreatography (ERCP)** and stenting before considering surgery.
Question 2: In acute pancreatitis, organ failure beyond 48 hours indicates:
- A. Critical pancreatitis
- B. Mild pancreatitis
- C. Moderately severe
- D. Severe pancreatitis (Correct Answer)
Explanation: ***Severe pancreatitis*** - **Severe pancreatitis** is defined by the presence of **persistent organ failure**, meaning organ failure lasting longer than 48 hours [1]. - This classification is crucial for predicting prognosis and guiding management, as severe pancreatitis carries a significantly higher risk of complications and mortality [1]. *Critical pancreatitis* - "Critical pancreatitis" is not a standard, recognized classification term in the revised Atlanta Classification for acute pancreatitis. - The classification primarily focuses on differentiating between mild, moderately severe, and severe forms based on local and systemic complications, particularly organ failure [1]. *Mild pancreatitis* - **Mild pancreatitis** is characterized by the absence of organ failure and local or systemic complications [1]. - Patients with mild pancreatitis typically have a benign course and recover without significant morbidity. *Moderately severe* - **Moderately severe pancreatitis** is defined by the presence of **transient organ failure** (resolves within 48 hours) or local complications (e.g., fluid collections, necrosis) without persistent organ failure [1]. - While more serious than mild pancreatitis, it does not involve the sustained organ dysfunction seen in severe cases.
Question 3: Most common immediate complication after splenectomy?
- A. Fistula
- B. Bleeding from gastric mucosa
- C. Pancreatitis
- D. Hemorrhage (Correct Answer)
Explanation: **Hemorrhage** - **Hemorrhage** is the most common immediate complication due to the spleen's rich blood supply and its close proximity to major vessels such as the **splenic artery and vein**. - Surgical trauma, inadequate ligation, or dislodgment of ligatures can lead to significant blood loss post-splenectomy. *Fistula* - Fistula formation, such as a **pancreatic fistula**, can occur but is less common immediately post-splenectomy compared to hemorrhage. - This complication typically develops due to injury to the **pancreatic tail** during splenic dissection, leading to leakage of pancreatic enzymes. *Bleeding from gastric mucosa* - Bleeding from the **gastric mucosa** (e.g., from stress ulcers or gastritis) is a potential complication after any major surgery but is not the most common immediate complication specific to splenectomy. - While the stomach is in close proximity, direct injury to the gastric mucosa causing significant bleeding is less frequent than hemorrhage from the splenic bed. *Pancreatitis* - **Pancreatitis** can be a severe complication of splenectomy, resulting from injury to the **pancreatic tail** during the procedure. - While it can manifest immediately, its incidence is generally lower than that of hemorrhage.
Question 4: Exocrine pancreatic insufficiency is seen in:
- A. Shwachman-Diamond syndrome (Correct Answer)
- B. Rubinstein-Taybi syndrome
- C. Seckel syndrome
- D. Diamond-Blackfan syndrome
Explanation: ***Shwachman-Diamond syndrome*** - This syndrome is characterized by **exocrine pancreatic insufficiency**, neutropenia, skeletal abnormalities, and growth retardation. - The pancreatic insufficiency leads to **malabsorption** and **steatorrhea** due to insufficient production of digestive enzymes. *Rubinstein-Taybi syndrome* - This syndrome is characterized by broad thumbs and great toes, intellectual disability, and distinctive facial features, but not primarily by exocrine pancreatic insufficiency. - It is caused by mutations in the **CREBBP** or **EP300** genes, which are not directly involved in pancreatic function. *Seckel syndrome* - This is a rare genetic disorder characterized by **primordial dwarfism**, microcephaly, and intellectual disability. - While it affects growth and development, it is not typically associated with exocrine pancreatic insufficiency. *Diamond-Blackfan syndrome* - This syndrome primarily involves **pure red cell aplasia**, leading to severe anemia. - Although it can have various congenital anomalies, **exocrine pancreatic insufficiency** is not a characteristic feature of this condition.
Question 5: Patients with chronic pancreatitis often exhibit a "chain of lakes" appearance in ERCP examinations. Management is?
- A. Total pancreatectomy
- B. Resecting the tail of pancreas and performing a pancreaticojejunostomy
- C. Sphincteroplasty
- D. Side to side pancreaticojejunostomy (Correct Answer)
Explanation: ***Side to side pancreaticojejunostomy*** - This procedure, specifically a **Puestow procedure**, is the gold standard for managing painful chronic pancreatitis with a dilated main pancreatic duct (≥6-7 mm) and multiple strictures, presenting as a "chain of lakes" on ERCP. - It involves dividing the small bowel, closing one end, and connecting the other to a longitudinal incision made along the dilated pancreatic duct, thereby allowing drainage of pancreatic secretions into the jejunum and alleviating pain. *Total pancreatectomy* - This is a highly morbid procedure reserved for very severe cases of chronic pancreatitis that are refractory to other treatments, often associated with unmanageable pain and severe exocrine and endocrine insufficiency. - It would necessitate lifelong **enzyme replacement therapy** and **insulin for diabetes**, indicating its use as a last resort. *Sphincteroplasty* - This procedure involves widening the sphincter of Oddi and is primarily used for **biliary obstruction** or **pancreatitis secondary to sphincter dysfunction**, not for the widespread strictures and dilated ducts typical of chronic pancreatitis with a "chain of lakes" appearance. - While it can improve drainage, it does not address the extensive ductal pathology seen in many cases of chronic pancreatitis with multiple strictures. *Resecting the tail of pancreas and performing a pancreaticojejunostomy* - This describes a **distal pancreatectomy with pancreaticojejunostomy**, which is suitable for lesions or pathologies primarily confined to the **body or tail of the pancreas**, such as certain tumors or cysts. - It would not effectively address the diffuse ductal changes and multiple strictures throughout the entire pancreas that cause the "chain of lakes" appearance in chronic pancreatitis, which usually requires decompression of the entire duct system.
Question 6: Which of the following is not considered a contraindication for pancreaticoduodenectomy?
- A. Metastasis
- B. Portal vein involvement (Correct Answer)
- C. Extensive invasion of superior mesenteric vein
- D. Stage III CA head of pancreas
Explanation: ***Portal vein involvement*** - While extensive portal vein invasion can make the procedure challenging, **segmental portal vein involvement without complete occlusion or direct invasion of the superior mesenteric artery** is often considered resectable with venous reconstruction and is not an absolute contraindication. - Advancements in surgical techniques and patient selection criteria allow for **safe resection and reconstruction of the portal vein** in carefully chosen cases, improving outcomes for patients who would otherwise be deemed inoperable. *Metastasis* - The presence of **distant metastases** (e.g., to the liver, peritoneum, or lungs) unequivocally indicates **Stage IV disease** and is an absolute contraindication to pancreaticoduodenectomy, as the surgery would not offer a curative benefit. - In such cases, systemic chemotherapy or palliative care is the more appropriate treatment approach, as resection would not alter the overall prognosis. *Stage III CA head of pancreas* - **Stage III carcinoma of the head of the pancreas** often implies **locally advanced disease** that involves major peripancreatic vessels, such as the superior mesenteric artery or celiac axis. - This level of extensive vascular involvement typically renders the tumor **unresectable**, making pancreaticoduodenectomy surgically unfeasible and a contraindication. *Extensive invasion of superior mesenteric vein* - **Extensive involvement of the superior mesenteric vein (SMV)**, particularly if it completely occludes the lumen or involves a long segment making reconstruction impossible, is generally considered a contraindication to pancreaticoduodenectomy. - While limited SMV involvement with reconstructive options might be resectable, **extensive, unreconstructable invasion** signifies locally advanced disease beyond surgical cure.
Question 7: Which of the following is not a recognized complication of chronic pancreatitis?
- A. Renal artery thrombosis (Correct Answer)
- B. Pancreatic pseudocyst
- C. Splenic vein thrombosis
- D. Pancreatic fistula
Explanation: ***Renal artery thrombosis*** - **Renal artery thrombosis** is generally associated with conditions like **atherosclerosis**, atrial fibrillation, or vasculitis, not directly with chronic pancreatitis. - While chronic pancreatitis can lead to systemic complications, direct renal arterial clotting is an atypical and **uncommon sequela**. *Pancreatic pseudocyst* - **Pancreatic pseudocysts** are common complications of chronic pancreatitis, occurring when fluid collections around the pancreas become walled off by fibrous tissue [1]. - They can cause pain, obstruction, and even rupture if left untreated [2]. *Splenic vein thrombosis* - **Splenic vein thrombosis** can result from inflammation and compression of the splenic vein by the diseased pancreatic tissue in chronic pancreatitis [1]. - This can lead to **splenomegaly** and **gastric varices** due to increased pressure in the portal system. *Pancreatic fistula* - A **pancreatic fistula** occurs when pancreatic fluid leaks from the gland, often forming a connection to another organ or the skin [2]. - This is a well-recognized complication of both acute and chronic pancreatitis, usually due to ductal disruption.
Question 8: Pancreatic pseudocysts developing complications are best managed by?
- A. Conservative treatment
- B. Surgery (Correct Answer)
- C. Radiologically guided interventions
- D. External drainage
Explanation: ***Surgery*** - When pancreatic pseudocysts develop **complications** (infection, hemorrhage, rupture, gastric outlet/biliary obstruction), definitive management is required. - Surgical internal drainage procedures (**cyst-gastrostomy**, **cyst-jejunostomy**, or **cyst-duodenostomy**) provide durable treatment by creating a permanent communication between the mature pseudocyst and the GI tract. - Surgery is particularly indicated when the pseudocyst has a **mature wall (>6 weeks)**, is **large (>6 cm)**, or when endoscopic approaches are not feasible or have failed. - While endoscopic drainage (EUS-guided) is increasingly used as first-line therapy, surgery remains the gold standard for complicated pseudocysts requiring definitive management, especially with complex anatomy or failed minimally invasive approaches. *Conservative treatment* - Conservative management with observation, pain control, and nutritional support is appropriate only for **asymptomatic, small (<6 cm)**, and **uncomplicated pseudocysts** with high likelihood of spontaneous resolution. - Once complications develop, conservative treatment is **inadequate** and poses risks of further deterioration. *Radiologically guided interventions* - Percutaneous drainage may be used for **infected pseudocysts** or as a temporizing measure, but carries high risk of **external fistula formation** (25-50%) and **recurrence**. - Does not provide internal drainage and is generally less effective than surgical or endoscopic internal drainage for complicated pseudocysts. - Not considered definitive management when complications are present. *External drainage* - External percutaneous catheter drainage is primarily a **temporizing measure** for critically ill patients or infected pseudocysts not amenable to other approaches. - High risk of **pancreaticocutaneous fistula** formation and does not address the underlying pancreatic duct communication. - Requires subsequent definitive management in most cases; not appropriate as primary treatment for complicated pseudocysts.
Question 9: After pancreaticoduodenectomy (PD surgery), when should the first postoperative follow-up visit be scheduled to assess the patient's recovery?
- A. 3 weeks
- B. 4 weeks
- C. 1 week
- D. 2 weeks (Correct Answer)
Explanation: ***2 weeks*** - A 2-week recall after **pancreaticoduodenectomy (PD surgery)** allows sufficient time for early postoperative complications to manifest while still being within a window for timely intervention. - This timeframe enables assessment of **wound healing**, resolution of ileus, nutritional status, and early recognition of issues like **pancreatic fistula** or **delayed gastric emptying**. *1 week* - A 1-week recall might be too early to identify some significant complications that typically present slightly later, such as **pancreatic fistula**. - At this stage, patients are often still in the acute recovery phase, making comprehensive outpatient assessment less informative. *3 weeks* - Delaying recall until 3 weeks might be too late for optimal management of certain **postoperative complications**, potentially leading to more severe outcomes. - Early symptoms of complications could be missed, increasing the risk of re-admission or prolonged recovery. *4 weeks* - By 4 weeks, many **early complications** that require timely intervention may have become more advanced or difficult to manage. - This recall period is often used for a more routine follow-up rather than immediate assessment of acute recovery.
Question 10: What is the median survival time for patients with carcinoma of the pancreas after surgery and adjuvant therapy?
- A. Approximately 12 months
- B. Approximately 32 months
- C. Approximately 22 months (Correct Answer)
- D. Approximately 44 months
Explanation: ***Approximately 22 months*** - The median survival for patients with **resectable pancreatic adenocarcinoma** treated with surgery (typically pancreaticoduodenectomy) and adjuvant chemotherapy is approximately **22-28 months** based on contemporary studies. - The 22-month figure represents a well-established median from multiple clinical trials including **ESPAC-1 and CONKO-001**, making it the most representative answer among the options provided. - This outcome reflects significant improvement from the pre-adjuvant therapy era but still underscores the aggressive biology of pancreatic cancer. *Approximately 12 months* - This figure represents **historical median survival** prior to the routine use of effective adjuvant chemotherapy, or survival in patients with **unresectable locally advanced disease** treated with palliative chemotherapy alone. - It is **not representative** of outcomes in patients who undergo complete surgical resection followed by modern adjuvant therapy. *Approximately 32 months* - While highly selected patients with **favorable tumor biology** (small tumors, negative margins, low CA 19-9) and optimal response to modern regimens like **FOLFIRINOX** may approach this survival, it exceeds the **median survival** for the general population of resected patients. - This represents the upper quartile rather than the median outcome. *Approximately 44 months* - This exceptionally long survival is **not achieved** as a median in pancreatic ductal adenocarcinoma, even with optimal surgical resection and adjuvant therapy. - Such prolonged survival is occasionally seen in **highly selected patients** or with less aggressive pancreatic neoplasms (e.g., neuroendocrine tumors, intraductal papillary mucinous neoplasms with invasive component), which have substantially better prognoses than typical ductal adenocarcinoma.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free